Philadelphia, May, 1961 , and at the American Medical Association Meeting, New York, June, 1961. tResearch Fellow of the Medical Research Council of Canada, 1958-61. tResearch Fellow of the Medical Research Council of Canada, 1960-2. observations on angiotensin infusions to patients with various types of hypertensive disease and of adrenal disorders.
Subjects and Methods Six normotensive subjects were studied; five were volunteer medical students whose medical history and physical examination were non-contributory. The sixth subject (G. P.) was studied while admitted to hospital for treatment of anxiety neurosis and minor gastro-intestinal symptoms. These subjects are not included in our previous publication (Biron et al., 1961) .
Eight patients with benign essential hypertension were selected for this study. They were free of any serious symptoms or complications and presented normal renal function. In addition, studies were made of one patient with coarctation of the aorta, two with Addison's disease, one with Cushing's syndrome, one with primary aldosteronism, and one who had been bilaterally adrenalectomized three years previously for primary aldosteronism (bilateral hyperplasia of the zona glomerulosa) (Genest, .
All subjects and patients were maintained on a fixed sodium and potassium intake (102 and 90 mEq /day, respectively) for five to six days prior to and during the experimental period. They were studied under metabolic balance conditions for the duration of the experiment. Urine was collected every 24 hours, except on infusion days, when it was collected during the day of infusion and again separately for the rest of the 24-hour period. Synthetic valine-5 angiotensin II aspartic /3-amide (Ciba) diluted in 5% glucose was infused at a rate sufficient to maintain an average increase in diastolic pressure of 25 to 33 mm. Hg in normal subjects and of 10 to 35 mm. Hg in hypertensive patients. In some subjects and patients angiotensin was also given at subpressor ratesthat is, at rates insufficient to raise the diastolic pressure by more than 5 mm. Hg. Results from control infusions of glucose 5%, adrenaline, and noradrenaline in normal subjects and hypertensive patients have been described previously (Genest, Nowaczynski, et al., 1960; Davis et al., 1961a) .
During infusions urine specimens were obtained by free voiding for hourly determination of creatinine clearance and electrolytes. To ensure adequate urine collection the patients were given an initial water load 5292 150Jin ,16 NITNI of 500 to 1,000 ml. two hours before the beginning of the experiment, and they received approximately 150 ml.
of water every hour until the end of the hourly collection periods. In all patients in whom creatinine clearance was measured the control periods consisted of two one-hour periods immediately before and after the angiotensin infusion. Creatinine was measured by Peters's (1942) method. Sodium and potassium were measured by flame photometry, using a Perkin-Elmer model 52 C and lithium as internal standards. The method for urinary aldosterone determination has been described by Nowaczynski et al. (1957) .
Results in Normal Subjects
The effects of pressor infusions of angiotensin for periods of one to eight hours in six normal subjects, on sodium excretion, and on creatinine clearance are shown in the Table. The percentage excretion of filtered sodium was calculated in assuming that the creatinine clearance gives a fairly close measurement of the glomerular filtration rate. All the results of creatinine clearances are corrected to 1.73 square metres of body surface area. Results of electrolytes and aldosterone excretion are expressed on a daily basis and do not take into account circadian rhythms. This way of presenting our data was the same for all subjects and patients studied. The trends observed are definite and the changes obtained are well above any variations due to diurnal variations.
The control sodium values before and after the angiotensin infusion consisted of its excretion during the day before and the night period following the infusion; the control creatinine clearance values consisted of the average of the two one-hour clearances before and after the infusion. The results indicate a mean decrease of 23O% in creatinine clearance during the infusion, although in two out of the six subjects there was essentially no change. These findings confirm those of Peart (1959) . Peart and Brown (1961) , and of Bock et al. (1958) and Bock and Krecke (1958) .
The effect of angiotensin infusions on sodium excretion was a marked reduction, averaging 63% for the group. The calculated excretion of the filtered load of sodium shows a 51 % decrease.
These results illustrate the magnitude of changes in tubular rejection of sodium as compared with that of glomerular filtration rate.
In subject R. L. the intense sodium retention with the marked fall in potassium excretion and in urinary Na/K ratio occurred without any significant change in creatinine clearance for the entire period of angiotensin infusion (Fig. 1) .
In two normal subjects pressor infusions of angiotensin were compared with infusions given at a rate insufficient to raise the blood-pressure significantly. In these two subjects the subpressor infusions were accompanied by a twofold rise in aldosterone excretion and marked sodium retention, as reported previously . When angiotensin was infused at a pressor rate these responses were even more marked.
Results in Patients with Benign Essential
Hypertension The effects of It infusions of angiotensin on aldosterone, sodium, and potassium excretion were studied in eight patients with benign essential hypertension. The duration of these infusions varied from 2.3 to 9 hours, the rate of angiotensin administration from 0.28 to 1.25 ,ug./min., and the increases in diastolic pressure from 6 to 26 mm. Hg. In each instance there was a significant increase in urinary aldosterone during the infusion period (Fig. 2) . In most cases this stimulation persisted through the post-infusion period covering the time from the cessation of infusion until the following morning. This response is somewhat similar to that observed in normal subjects, where the average aldosterone excretion values of normotensive subjects include also those obtained in the subjects previously studied by us (Biron et al., 1961) .
In all cases, and in contrast to the response of normal subjects, a significantly increased sodium excretion occurred during the infusions, in spite of the aldosterone stimulation. This phenomenon reverted to e On a fixed Na and K intake (102 and 90 mEq 'day, respectively).
t Percentages for control periods " before " were derived by using the sodium excretion for the entire 24-hour period preceding the infusions and the mean creatinine clearances f.r the two-hour period immediately precedine the infusion.
$ This second infusion was given under the same conditions as the first.
retention immediately after the cessation of infusion, while aldosterone stimulation still persisted (Fig. 3) . The typical effect of a pressor infusion in a patient with essential hypertension is shown in Fig. 4 excretion of sodium and range before, during, and after pressor infusions of angiotensin in 11 normal subjects and eight patients with essential hypertension (10 experiments). In contrast to the normal subjects and despite the greatly increased aldosteronuria, all patients with essential hypertension showed during the angiotensin infusions a marked natruresis, which was followed by severe sodium retention immediately after cessation of the infusion. These subjects and patients are the same as those of Fig. 2 M. L. a second pressor infusion of angiotensin given two days after the first infusion did not result in the same degree of natruresis.
The excretion of the filtered load of sodium in these hypertensive patients was increased by 323% as an average of the group, and shows strikingly the fundamental difference in tubular handling of sodium which exists between normals and hypertensives in response to angiotensin.
The overall effect on sodium excretion in patients with essential hypertension is compared with that observed in normal subjects (Fig. 3) . While the period of infusion is characterized by a marked natruresis in hypertensive patients in contrast to sodium retention in normals, the post-infusion period shows the same degree of sodium retention in both groups.
Results in Patients with Adrenocortical Disorders
Two patients with Addison's disease who were being maintained on replacement therapy with hydrocortisone (30 mg./day) and a sodium chloride intake of 9 g./day were given three-hour pressor infusions of angiotensin. In both cases aldosterone excretion during the infusion was increased fourfold and twofold, respectively. The effect on sodium excretion was similar to that observed in normal subjects, the observed decrease being threefold and fivefold, respectively. Patient H. B., whose case has been previously reported in detail (Genest, Koiw, et al., 1960) A large body of evidence, reviewed by Tobian (1960a Tobian ( , 1960b has suggested a relationship between renin, the adrenal zona glomerulosa (or "mineralocorticoid" hormone), and sodium. Of particular interest was the demonstration, by Deane and Masson (1951), Hartroft et al. (1959) , and Gross (1960) , that renin administration increases the width of the adrenal zona glomerulosa in rats. It was shown in this laboratory that hypertensive infusions of angiotensin in normal subjects are accompanied and/or followed by a twofold to elevenfold increase in aldosterone excretion (Biron et al., 1960 (Biron et al., , 1961 Genest, Nowaczynski, et al., 1960; This was soon confirmed by Laragh et al. (1960) , who reported the stimulatory action of angiotensin on aldosterone secretion rate in normotensive subjects. Studies by Mulrow and Ganong (1961), Slater et al. (1961) , Davis et al. (1961a Davis et al. ( , 1961b Davis et al. ( , 1961c , and Carpenter et al. (1961) in nephrectomized dogs showed that renin and angiotensin infusions promptly and markedly increased aldosterone secretion, and also stimulated the production of 17-hydroxycorticosteroids, although to a less extent. These findings in dogs may indicate a species difference, since such effects on the 17-hydroxycorticoids in normal human subjects were generally smaller in magnitude or absent Genest et al., 1961 .
Angiotensin was detected in the blood of only one out of five patients with Conn's syndrome (Biron et al., 1962) (in this patient, angiotensinaemia was well within the range of normal subjects), using the procedure of Boucher et al. (1961) ; the evidence available at the present time does not suggest that angiotensin liberation is responsible for the hyperaldosteronism of Conn's syndrome. Our studies of blood angiotensin levels (Biron et al., 1962) in patients with various types of hypertension even suggest at this time that angiotensin may be more concerned with the maintenance of " normal " blood-pressure than with the production of hypertensive disease and are in agreement with Gross's (1960) observations. The prevention of aldosterone stimulation secondary to haemorrhage in dogs by nephrectomy (Davis et al., 1961a (Davis et al., , 1961b (Davis et al., , 1961c Carpenter et al., 1961) indicates that, at least in this experimental condition, the renal pressor system is responsible for hyperaldosteronism.
The stimulation of the zona glomerulosa does not seem to be dependent upon the systemic increase in blood-pressure, since subhypertensive infusions of angiotensin are effective, and infusions with other pressor agents (noradrenaline, phenylephrine, and adrenaline) are not (Brouillet and Genest, 1958; Genest et al., 1961) . The exact mechanism of action of angiotensin on the adrenal cortex remains to be demonstrated.
The present study indicates that hypertensive patients respond to angiotensin in the same fashion as normotensives so far as aldosterone excretion is concerned.
Studying the effects of 50-minute infusions of angiotensin in normal subjects, Bock and Krecke (1958) observed an initial fall in para-aminohippuric acid (P.A.H.) and inulin clearance which tended to return to pre-control values during the infusion; the excretion of sodium was markedly depressed, and that of potassium to a less extent. During 45 minutes' infusions, Barrett et al. (1961) found that angiotensin reduced urine volume by as much as 85 %, inulin clearance up to 45%, and that of P.A.H. up to 60%, in normotensive subjects. Peart (1959) observed a reduction of both clearances, with a slight increase in filtration fraction, accompanied by a marked sodiumand-water retention. The studies of our group (Biron et al., 1960 (Biron et al., , 1961 Genest, Nowaczynski, et al., 1960; , and of those of Laragh et al. (1960) , Peart (1959) , and Peart and Brown (1961) (1957) . But a more thorough study made by Peart and Brown (1961) the striking difference in the sodium excretory response of the hypertensive patients as compared with the normal subjects; the 323% increased excretion of the filtered load of sodium observed in hypertensive patients in response to angiotensin stands in marked contrast to the 51% reduction noted in normal subjects, strongly suggesting that angiotensin has opposite effects on the tubular handling of sodium in these two groups of subjects.
The patient with coarctation of the aorta behaved like Q normal subject with respect to sodium excretion. Peart and Brown (1961) have found that acute lowering of systemic blood-pressure does not alter the natruretic response in hypertensives, but in five patients with hypertension they observed a return to a normal sodium response after a few months of niormotension following nephrectomy or drug therapy. Del Greco (1961) has found that, in one patient with advanced essential hypertension, angiotensin infusion under conditions of sodium retention promoted natruresis and diuresis while it tended to cause a decreased excretion of salt and water under conditions of sodium depletion. This interesting observation does not apply readily to our findings, however, since our patients had normal renal function and were receiving a " normal" salt intake (6 g. /day).
Summary and Conclusion
Angiotensin infusions lasting from one to six hours in six normotensive subjects caused an average drop of 23 % in creatinine clearance and of 63 % in sodium excretion. Similar infusions in six patients with essential hypbrtension caused an average fall of 5% in creatinine clearance but a 290% increase in sodium excretion. A similar natruretic response was obtained in one patient with Cushing's syndrome and one with primary aldosteronism, while sodium retention occurred in one bilaterally adrenalectomized patient, two patients with Addison's disease, and one patient with coarctation of the aorta. The hourly values of creatinine clearance and of sodium excretion did not show a close relationship between these two parameters.
In all normal subjects and hypertensive patients studied, angiotensin caused a consistent and marked increase in aldosterone excretion during its administration. This effect persisted during the post-infusion period, at which time it was accompanied by marked sodium retention. The metabolic effects of angiotensin infusions may be produced without increasing the systemic blood-pressure, since subpressor infusions had qualitatively similar effects to those obtained by infusions given at pressor rates.
The greater effect on sodium tubular reabsorption than on glomerular filtration rate in normotensive subjects Physician, St. David's Hospital, Cardiff The purpose of this paper is to assess the value and risks of long-term steroid therapy in severe chronic asthma. The observations are based on 317 asthmatic out-patients treated with steroids for periods of from four months to seven years, with an average duration of two and a half years: 205 have been on steroids for over two years, 118 for over three years, 46 for over four years, and 12 for over five years.
Steroids were first described as beneficial in asthma by Bordley et al. (1949) . The Medical Research Council (1956a) confirmed their efficacy in status asthmaticus but doubted their value in the long-term treatment of chronic asthma (M.R.C., 1956b).
There are now many favourable reports on the value of long-term steroid therapy in chronic intractable asthma (Gay et al., 1954; Arnoldsson, 1958; Williams, 1959; Phear et al., 1960; Serafini, 1960; Andersson and Bruun, 1960; Herxheimer, 1961; Pearson et al., 1961; Livingstone and Davies, 1961; Baldwin et al., 1961) . That there is still confusion of thought on this subject is shown by the recent communications of Grant (1961 ), Asher (1961 ), Maxwell (1961 ), and Hart and Emerson (1961 .
Materials and Methods Care has been taken to include only patients with asthma, which we have defined as recurrent spontaneous attacks of dyspnoea and wheeziness, commonly occurring at night, due to a functional bronchiolar obstruction with a characteristic pathology (Gough, 1960) . The numbers of patients with associated conditions are shown in Table I . Care was taken to include only those with " chronic intractable asthma " in whom all other measurev had failed; 133 patients (42%) had had repeated status asthmaticus. The pretreatment assessment is shown in Table IV . Of these 317 patients, 84% were to a greater or less degree chronically incapacitated, 32% permanently so. All of the 16% not incapacitated had considerably disturbed sleep at night and were dyspnoeic on exertion in spite of treatment. During the last two years all patients *Now at Liandough Hospital, Cardiff.
had simple lung-function tests before and during steroid therapy. No patients were started on steroid therapy unless they had a very low forced expiratory volume in 1 second (F.E.V.1) and forced vital capacity (F.V.C.), and none were maintained on steroid therapy unless there had been a marked increase in the F.E.V.1 and F.V.C. over an initial period of two weeks. This improvement was generally maintained except when other factors such as a chest infection supervened.
We would regard as a typical response an F.E.V., of 750 ml., an F.V.C. of 1,533 ml., and an F.E.V.% 48; 14 days later F.E.V.1 2,233 ml., F.V.C. 3,400 ml., and F.E.V. % 60.
Patients were skin-tested as indicated by the clinical history and hyposensitization was carried out in appropriate cases. An E.N.T. surgeon (Mr. Alun Thomas) and a psychiatrist (Dr. Cyril Jenkins) examined and treated appropriate patients.
The age-and-sex distribution is shown in 
